The management team includes entrepreneurs with successful IPO/acquisition exits, world class scientists, renowned scientific advisors, and a board with experienced pharma, technology and healthcare executives.
Eric Hunter
CEO & Director
Eric serves as the Company’s Chief Executive Officer. Mr. Hunter is author or co- author on over 130 patents. He has extensive experience in the founding and managing a range of businesses in the high technology, manufacturing and medical device industries. Two of these companies including CREE Inc. are publicly traded on Nasdaq. Mr. Hunter also co-founded a medical device company, Quill Medical, which was sold to Angiotech Pharmaceuticals, Inc. for $200 million in 2005 and an eye care company, Corinthian Ophthalmic, Inc., that was sold to Eyenovia, Inc. in 2014.
Jack Hebrank, PhD
Chief Scientific OFficer
Jack serves as Pneuma’s Chief Scientific Officer. With a PhD in Mechanical and Electrical Engineering from Duke University, Dr. Hebrank taught fluid mechanics for 18 years at North Carolina State University. He also has had an impressive career as Director of Technical Development for Embrex from 1997-2007. After Embrex was acquired by Pfizer, Dr. Hebrank served as Senior Principal Scientist for Pfizer from 2007-2015.
Chao Ping “Ryan” Lee
Director Asia
Ryan serves as Pneuma’s Director of Asia. Mr. Lee holds a MBA in Management Science and a MEng in Mechanical Engineering. Most recently, Mr. Lee was President of Sunnytec Electronics, a leader in Piezo manufacturing. Ryan has 20+ years of experience in Piezo ceramics material, ultrasonic and micro fluid application. His illustrious career also includes 35+ patents in Taiwan and the United States as well as receiving the National Innovation Award in Taiwan.
Jay Morgan
Chairman
The former Chief Operating Officer for Research Operations at Merck Consumer Health, serves as the Chairman of the Board. At Merck, he led global product development and founded a Human Centered Design team as Vice President of Innovation. Further, Mr. Morgan has also led innovation for Bayer Consumer Health as VP Global Innovation & Design. As a founding member of the non-profit Memphis Innovation Bootcamp, Mr. Morgan is committed to helping equip community leaders, businesses and educators realize a better future through innovation best practices.
Walt Robb, PhD.
Director
A former Senior VP of General Electric, serves as a Director and is a liaison to the medical device industry. In his career at GE, Dr. Robb led GE Medical (now GE Healthcare) for 13 years and GE Corporate R&D for 6 years. He grew GE Medical from 1,000 to 10,000 employees. Dr. Robb received the National Medal of Technology from President Clinton for his leadership in the CT and MR imaging industry.
Eric Hunter
CEO & Director
Eric serves as the Company’s Chief Executive Officer. Mr. Hunter is author or co- author on over 130 patents. He has extensive experience in the founding and managing a range of businesses in the high technology, manufacturing and medical device industries. One of these companies, Cree Inc., is publicly traded on Nasdaq. Mr. Hunter also co-founded a medical device company, Quill Medical, which was sold to Angiotech Pharmaceuticals, Inc. for $200 million in 2005 and an eye care company, Corinthian Ophthalmic, Inc., that was sold to Eyenovia, Inc. in 2014.
Knox Singleton
Director
Until his retirement in July 2018, Mr. Singleton, served for 35 years as the CEO of Inova Health System, the largest employer in Northern Virginia, where he oversaw the evolution of Inova from a three hospital, $500 million enterprise with 1,000 employees to a $3.5 billion healthcare system with five hospitals, a health insurance company and over a hundred ambulatory service locations, 17,000 employees, and 2,000,000 patients system-wide. Mr. Singleton has received numerous awards during his career in recognition of his leadership in the field of health care.
Douglas Stoner
Director
Special Council for Hoffman Warnick LLC, a leading Boston-based intellectual property law office, serves as a Director. Much of Mr. Stoner’s practice is devoted to licensing matters and cooperative research agreements directed toward maximizing the impact of IP on profits. Prior to joining Hoffman Warnick LLC, he enjoyed a 28-year career with General Electric where he served as chief IP Counsel at GE Medical Systems for 14 years and as General Counsel at GE Corporate Research and Development for 9 years. Mr. Stoner directed GE’s IP departments in the US, France, Japan and India.